{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:29Z","timestamp":1790187089499,"version":"4.1.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/14787210.2021.1886923","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:18:40Z","timestamp":1612916320000},"page":"1107-1116","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review"],"prefix":"10.1080","volume":"19","author":[{"given":"Sean N.","family":"Avedissian","sequence":"first","affiliation":[{"name":"Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE, USA"},{"name":"University of Nebraska Medical Center, College of Pharmacy, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanial J.","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Midwestern University College of Pharmacy, Downers Grove Campus, Downers Grove, IL, USA"},{"name":"Midwestern University College of Pharmacy, Downers Grove Campus, Pharmacometrics Center of Excellence, Downers Grove, IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Shaffer","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, College of Pharmacy, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tran","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics, University of California San Diego School of Medicine and Rady Children\u2019s Hospital San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Le","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1112"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.174"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817001571"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2018.259"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.11.023"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2017.1405276"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001753"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002349"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy509"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115108"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000652"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01949-09"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0183"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2014.91"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199733010-00004"},{"key":"cit0016","unstructured":"Vancomycin (vancomycin for injection), and [package insert]. APP Pharmaceuticals, LLC, Schaumburg, IL."},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000078160.29072.42"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000086956.45566.55"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000087020.75886.93"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2164"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200208000-00025"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000086954.43010.63"},{"key":"cit0024","unstructured":"ZYVOX (Linezolid for injection), and [package insert]. Last revised: May 2008, Pfizer, Division of Pfizer Inc. NY. NY."},{"key":"cit0025","unstructured":"SIVEXTRO (tedizolid for injection, oral tablets), and [package insert]. Last revised: June 2020, Merck Sharp & Dohme Corp, Whitehouse Station, NJ."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001096"},{"key":"cit0027","unstructured":"DALVANCE (dalbavancin for injection), and [package insert]. Last revised: May 2014. Durata Therapeutics: Chicago, IL."},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2477"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318286378e"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03620-14"},{"key":"cit0032","first-page":"3","author":"Lodise TP","year":"2019","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz051"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu110"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01653-13"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000039"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.06.003"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000646"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001538"},{"issue":"2","key":"cit0040","first-page":"iv23","volume":"98","author":"Garazzino S","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000088671.35064.7c"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000086955.93702.c7"},{"issue":"3","key":"cit0043","first-page":"696","volume":"48","author":"Moran GJ","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001926"},{"issue":"11","key":"cit0045","first-page":"962","volume":"77","author":"Syrogiannopoulos GA","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002790"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211898"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31825d2fa2"},{"key":"cit0049","volume-title":"Last revised","author":"CUBICIN (daptomycin for injection), and [package insert]","year":"2017"},{"key":"cit0050","unstructured":"FDA Drug Safety Communication: Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections. [cited 2020 Dec 9]. Available at https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-increased-risk-death-tygacil-tigecycline-compared-other-antibiotics."},{"key":"cit0051","unstructured":"Tygacin (tigecycline for injection), and [package insert]. Last revised: July 2010."},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.010"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp503"},{"key":"cit0054","unstructured":"TEFLARO (Ceftaroline for injection), [package insert]. Last revised: November 2010, Forest Laboratories Inc: St. Louis, MO."},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz538"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02015-16"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku378"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku322"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00502-12"},{"key":"cit0060","unstructured":"A Multi-center Prospective Randomized Open Label Study of Utilizing Interleukin 10 (IL-10) Levels as a Guide for Antibiotic Selection for Methicillin Resistant Staphylococcus Aureus Bacteremia. (2017). [cited 2020 Dec 9]. Retrieved from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02660346(ClinicalTrials.gov Identifier: NCT02660346)"},{"issue":"5","key":"cit0061","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02483-18","volume":"63","author":"Geriak M","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001191"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001159"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002607"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.809"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23827"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00029-07"},{"issue":"5","key":"cit0068","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00106-20","volume":"64","author":"Kumar V","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu219"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.03.010"},{"key":"cit0071","unstructured":"A Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole Medocaril Compared to Daptomycin in the Treatment of Staphylococcus Aureus Bacteremia, Including Infective Endocarditis. (2018). [cited 2020 Dec 9]. Retrieved from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03138733. (ClinicalTrials.gov Identifier: NCT03138733)"},{"key":"cit0072","unstructured":"Monurol (fosfomycin tromethamine), and [package insert]. Last revised: Feb 2011."},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2015.03.015"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv319"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.12.005"},{"key":"cit0076","unstructured":"XENELTA (lefamulin for injection), and [package insert]. Last revised: August 2019, Nabriva Therapetuics: Ireland DAC."},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz084"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz090"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00313-18"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00209-19"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394438-2.00003-7"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.3390\/v11010018"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2021.1886923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:45:02Z","timestamp":1641296702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2021.1886923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/14787210.2021.1886923"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2021.1886923","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}